New means to monitor the effect of glucocorticoid therapy in children

Table 2 Concentration of IFNγ and IL-5 (pg/mL)

Patient No.	IFNγ A PHA	IFNγ B PHA	IL-5 A PHA	IL-5 B PHA
1	7200	19 000	11	28
2	99 000	8500	0.0	0.0
3	41 000	12 000	77	19
4	82 000	17 000	150	9.3
5	94 000	36 000	150	11
6	> 120 000	> 120 000	54	21
7	> 120 000	100 000	140	38
8	63 000	28 000	1.2	1.2
9	59 000	34 000	99	34
10	110 000	120 000	75	89
11	> 120 000	84 000	8.1	1.2
12	> 120 000	85 000	12	3.5
13	91 000	19 000	84	17
14	40 000	62 000	73	130
15	91 000	6600	10	7.2
16	> 120 000	> 120 000	15	2.3
17	90 000	63 000	69	33
18	> 120 000	97 000	33	0.0
19	68 000	120 000	89	160

Measured with ELISA in the supernatants of healthy donor PBMCs (target cells, stimulated with PHA) cultured with patient serum taken before (A) and 2 wk after oral GC therapy (B).